Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry L Sharaf

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
JACC. Cardiovascular Interventions|June 23, 2018
Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT RegistryDhaval Kolte, Sahil Khera, Sreekanth Vemulapalli, et al.
Journal of Women'S Health (2002)|August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
American Heart Journal|August 9, 2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseOscar C Marroquin, Kevin E Kip, Suresh R Mulukutla, et al.
Cardiovascular Diagnosis and Therapy|October 18, 2016
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Mark Doyle, Gerald M Pohost, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) StudyEileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Journal of the American College of Cardiology|February 7, 2006
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) StudyGretchen L Gierach, B Delia Johnson, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|June 3, 2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation StudyChristopher B Arant, Timothy R Wessel, Marian B Olson, et al.
Journal of Women'S Health (2002)|January 27, 2005
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyB Delia Johnson, C Noel Bairey Merz, Glenn D Braunstein, et al.
Journal of Women'S Health (2002)|September 9, 2008
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Leslee J Shaw, C Noel Bairey Merz, Vera Bittner, et al.
Cardiovascular Diagnosis and Therapy|June 2, 2017
Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Mark Doyle, Gerald M Pohost, C Noel Bairey Merz, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
JACC. Cardiovascular Interventions|June 23, 2018
Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT RegistryDhaval Kolte, Sahil Khera, Sreekanth Vemulapalli, et al.
Journal of Women'S Health (2002)|August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
American Heart Journal|August 9, 2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery diseaseOscar C Marroquin, Kevin E Kip, Suresh R Mulukutla, et al.
Cardiovascular Diagnosis and Therapy|October 18, 2016
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Mark Doyle, Gerald M Pohost, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|February 7, 2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) StudyEileen Handberg, B Delia Johnson, Christopher B Arant, et al.
Journal of the American College of Cardiology|February 7, 2006
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) StudyGretchen L Gierach, B Delia Johnson, C Noel Bairey Merz, et al.
Journal of the American College of Cardiology|June 3, 2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation StudyChristopher B Arant, Timothy R Wessel, Marian B Olson, et al.
Journal of Women'S Health (2002)|January 27, 2005
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyB Delia Johnson, C Noel Bairey Merz, Glenn D Braunstein, et al.
Journal of Women'S Health (2002)|September 9, 2008
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Leslee J Shaw, C Noel Bairey Merz, Vera Bittner, et al.
Cardiovascular Diagnosis and Therapy|June 2, 2017
Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Mark Doyle, Gerald M Pohost, C Noel Bairey Merz, et al.
Pageof 6